224 related articles for article (PubMed ID: 27323782)
21. Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer.
Zhang X; Hua R; Wang X; Huang M; Gan L; Wu Z; Zhang J; Wang H; Cheng Y; Li J; Guo W
Oncotarget; 2016 Mar; 7(9):9815-31. PubMed ID: 26769843
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY
J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373
[TBL] [Abstract][Full Text] [Related]
23. KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer.
Ribeiro KB; da Silva Zanetti J; Ribeiro-Silva A; Rapatoni L; de Oliveira HF; da Cunha Tirapelli DP; Garcia SB; Feres O; da Rocha JJ; Peria FM
Cancer Biomark; 2016 Mar; 16(4):513-21. PubMed ID: 27062566
[TBL] [Abstract][Full Text] [Related]
24. CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer.
Go SI; Ko GH; Lee WS; Kim RB; Lee JH; Jeong SH; Lee YJ; Hong SC; Ha WS
Cancer Res Treat; 2016 Jan; 48(1):142-52. PubMed ID: 25779358
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma.
Nguyen PH; Giraud J; Chambonnier L; Dubus P; Wittkop L; Belleannée G; Collet D; Soubeyran I; Evrard S; Rousseau B; Senant-Dugot N; Mégraud F; Mazurier F; Varon C
Clin Cancer Res; 2017 Mar; 23(6):1586-1597. PubMed ID: 27620279
[No Abstract] [Full Text] [Related]
26. De-novo expression of CD44 and survival in gastric cancer.
Mayer B; Jauch KW; Günthert U; Figdor CG; Schildberg FW; Funke I; Johnson JP
Lancet; 1993 Oct; 342(8878):1019-22. PubMed ID: 7692200
[TBL] [Abstract][Full Text] [Related]
27. ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker.
Zhang M; Zhang C; Du W; Yang X; Chen Z
Clin Transl Oncol; 2016 Aug; 18(8):776-81. PubMed ID: 26527032
[TBL] [Abstract][Full Text] [Related]
28. Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer.
Setälä L; Lipponen P; Tammi R; Tammi M; Eskelinen M; Alhava E; Kosma VM
Histopathology; 2001 Jan; 38(1):13-20. PubMed ID: 11135041
[TBL] [Abstract][Full Text] [Related]
29. Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma.
Jung WY; Kang Y; Lee H; Mok YJ; Kim HK; Kim A; Kim BH
Histopathology; 2013 Oct; 63(4):474-81. PubMed ID: 23889297
[TBL] [Abstract][Full Text] [Related]
30. Comparison of EpCAM
Liu M; Di J; Liu Y; Su Z; Jiang B; Wang Z; Su X
Cancer Biol Ther; 2018; 19(10):939-947. PubMed ID: 29580161
[TBL] [Abstract][Full Text] [Related]
31. GLI2 induces PDGFRB expression and modulates cancer stem cell properties of gastric cancer.
Wang JX; Zhou JF; Huang FK; Zhang L; He QL; Qian HY; Lai HL
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3857-3865. PubMed ID: 28975979
[TBL] [Abstract][Full Text] [Related]
32. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the prognostic value and functional roles of CD44v6 in gastric cancer.
Xie JW; Chen PC; Zheng CH; Li P; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Lin Y; Huang CM
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1809-17. PubMed ID: 25809905
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
[TBL] [Abstract][Full Text] [Related]
35. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of intraperitoneal CD44 mRNA levels of magnetically separated CD45-negative EpCAM-positive cells for peritoneal recurrence and prognosis in stage II and III gastric cancer patients.
Horikawa M; Iinuma H; Inoue T; Ogawa E; Fukushima R
Oncol Rep; 2011 May; 25(5):1413-20. PubMed ID: 21331451
[TBL] [Abstract][Full Text] [Related]
37. Increased CD44 Expression and MEK Activity Predict Worse Prognosis in Gastric Adenocarcinoma Patients Undergoing Gastrectomy.
Lin JX; Yoon C; Li P; Yu Q; Qiu SL; Zheng CH; Yoon SS; Huang CM
J Gastrointest Surg; 2021 May; 25(5):1147-1155. PubMed ID: 32410176
[TBL] [Abstract][Full Text] [Related]
38. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
[TBL] [Abstract][Full Text] [Related]
39. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
Liu J; Liu Z; Zhang X; Gong T; Yao D
BMC Cancer; 2019 Mar; 19(1):227. PubMed ID: 30866865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
